Inventor · disambiguated record
Troy Vickers
Also filed as: VICKERS TROY · VICKERS TROY D
15 granted patents·9 pending applications·32 citations·filing 2004–2024
91Inventor score
Files withDART NEUROSCIENCE CAYMAN LTD14DART NEUROSCIENCE LLC5NEUROCRINE BIOSCIENCES INC3DYCK BRIAN1VERTEX PHARMA1
Top patents by PatentIndex Score
24 records- 0194US9175010B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Nov 3, 2015·12 cites·17 claims
- 0288US9932345B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Apr 3, 2018·3 cites·35 claims
- 0387US9533996B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 0487US2025122172A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0586US9499562B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2013·Granted Nov 22, 2016·3 cites·27 claims
- 0685US2025092047A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0784US10092575B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 9, 2018·3 cites·10 claims
- 0881US9120770B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Sep 1, 2015·3 cites·30 claims
- 0979US2023075774A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1078US11186582B2Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 1178US9040692B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted May 26, 2015·2 cites·1 claims
- 1277US2023192698A1Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl compounds as pde2 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1374US9573937B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Feb 21, 2017·1 cites·20 claims
- 1473US11279691B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE LLC·Filed 2019·Granted Mar 22, 2022·0 cites·4 claims
- 1571US10376514B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Aug 13, 2019·0 cites·20 claims
- 1665US2018346448A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Application pending·0 cites
- 1764US2016009691A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Application pending·0 cites
- 1862US10105367B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 23, 2018·0 cites·20 claims
- 1961US10501465B2Substituted [1,2,4]triazolo[1,5-A]pyrimidin-7-yl compounds as PDE2 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 2059US8293729B2Compounds, pharmaceutical composition and methods relating theretoDYCK BRIAN·Filed 2010·Granted Oct 23, 2012·1 cites·20 claims
- 2156US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2255US7067509B2Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Granted Jun 27, 2006·1 cites·59 claims
- 2342US2006178403A1Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 2440US2005256124A1Melanin-concentrating hormone receptor antagonists and compositions and methods related theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →